Bank of America
AIM

Bank of America’s AIM ImmunoTech AIM Stock Holding History

Bank of America’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28
Closed -$32 – 7226
2025
Q4 		$32 Buy
28
+1
+4% +$2 ﹤0.01% 7042
2025
Q3 		$74 Buy
27
+22
+440% +$98 ﹤0.01% 7919
2025
Q2 		$43 Hold
5
– – ﹤0.01% 8136
2025
Q1 		$61 Hold
5
– – ﹤0.01% 7935
2024
Q4 		$95 Buy
5
+1
+25% +$23 ﹤0.01% 7749
2024
Q3 		$116 Hold
4
– – ﹤0.01% 7692
2024
Q2 		$146 Buy
+4
New +$170 ﹤0.01% 7628
2024
Q1 		– Sell
-1
Closed -$41 – 8436
2023
Q4 		$26 Buy
+1
New +$47 ﹤0.01% 7612
2023
Q3 		– Sell
-50
Closed -$3.08K – 8192
2023
Q2 		$3.35K Buy
+50
New +$2.41K ﹤0.01% 7062
2023
Q1 		– Sell
-1
Closed -$52 – 8720
2022
Q4 		$34 Buy
+1
New +$46 ﹤0.01% 7875
2022
Q3 		– Hold
0
– – – 8638
2022
Q2 		– Sell
-150
Closed -$14.4K – 8864
2022
Q1 		$16K Sell
150
-1
-0.7% -$86 ﹤0.01% 7617
2021
Q4 		$14K Sell
151
-6
-4% -$928 ﹤0.01% 7633
2021
Q3 		$31K Buy
157
+7
+5% +$1.41K ﹤0.01% 7255
2021
Q2 		$32K Sell
150
-1
-0.7% -$214 ﹤0.01% 7003
2021
Q1 		$34K Buy
151
+1
+0.7% +$226 ﹤0.01% 6755
2020
Q4 		$27K Sell
150
-17
-10% -$3.4K ﹤0.01% 6522
2020
Q3 		$36K Buy
167
+6
+4% +$1.5K ﹤0.01% 6137
2020
Q2 		$39K Sell
161
-33
-17% -$8.01K ﹤0.01% 6087
2020
Q1 		$50K Buy
194
+162
+506% +$25.4K ﹤0.01% 5878
2019
Q4 		$2K Sell
32
-70
-69% -$3.51K ﹤0.01% 6937
2019
Q3 		$8K Buy
+102
New +$24.7K ﹤0.01% 6774
2019
Q2 		– Hold
0
– – – 7702
2016
Q3 		– Hold
0
– – – 7788
2016
Q2 		– Hold
0
– – – 7815
2014
Q4 		– Sell
-1
Closed -$10K – 8503
2014
Q3 		$10K Hold
1
– – ﹤0.01% 7357
2014
Q2 		$9K Hold
1
– – ﹤0.01% 7524
2014
Q1 		$12K Hold
1
– – ﹤0.01% 7157
2013
Q4 		$8K Hold
1
– – ﹤0.01% 7381
2013
Q3 		$7K Hold
1
– – ﹤0.01% 7319
2013
Q2 		$7K Buy
+1
New +$11.9K ﹤0.01% 7293

Other funds holding AIM

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CB
Community Bank Dewitt, New York $840M AUM 22.23% 1-Year Est. Return

Bank of America's AIM Position: Q1 2026 in Review

Bank of America sold out of AIM ImmunoTech (AIM) in Q1 2026, closing a stake of 28 shares — an estimated $32 sold.

Bank of America first reported a position in AIM in Q2 2013 and held it in 27 quarters. The position peaked at $50K in Q1 2020. 18 funds tracked by Wall St. Rank hold AIM as of Q1 2026.

  • Bank of America reported no remaining AIM ImmunoTech position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 28 AIM ImmunoTech shares in Q1 2026, an estimated $32.
  • Bank of America first reported a position in AIM ImmunoTech in Q2 2013 and held it in 27 quarters.
  • Bank of America's AIM ImmunoTech position peaked at $50K in Q1 2020.
  • 18 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.